{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:00:10Z","timestamp":1789992010351,"version":"4.0.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02361-4","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T12:25:53Z","timestamp":1782563153000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Joint association of body roundness index and HOMA-IR with risk of MASLD in Korean populations"],"prefix":"10.1186","volume":"26","author":[{"given":"Kyo-sun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Ho","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Hye","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Jae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"key":"2361_CR1","doi-asserted-by":"publisher","first-page":"155217","DOI":"10.1016\/j.metabol.2022.155217","volume":"133","author":"C Boutari","year":"2022","unstructured":"Boutari C, Mantzoros CS. A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on. Metabolism. 2022;133:155217.","journal-title":"Metabolism"},{"issue":"3","key":"2361_CR2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","volume":"13","author":"F Rubino","year":"2025","unstructured":"Rubino F, Cummings DE, Eckel RH, Cohen RV, Wilding JPH, Brown WA, Stanford FC, Batterham RL, Farooqi IS, Farpour-Lambert NJ, et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025;13(3):221\u201362.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2361_CR3","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.2147\/JIR.S503648","volume":"18","author":"D Shen","year":"2025","unstructured":"Shen D, Cai X, Hu J, Song S, Zhu Q, Ma H, Zhang Y, Ma R, Zhou P, Yang W, et al. Inflammatory indices and MAFLD prevalence in hypertensive patients: a large-scale cross-sectional analysis from China. JIR. 2025;18:1623\u201338.","journal-title":"JIR"},{"issue":"Suppl","key":"2361_CR4","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","volume":"31","author":"ZM Younossi","year":"2025","unstructured":"Younossi ZM, Kalligeros M, Henry L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. CMH. 2025;31(Suppl):S32\u201350.","journal-title":"CMH"},{"issue":"5","key":"2361_CR5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1161\/CIR.0000000000000223","volume":"132","author":"G Rao","year":"2015","unstructured":"Rao G, Powell-Wiley TM, Ancheta I, Hairston K, Kirley K, Lear SA, North KE, Palaniappan L, Rosal MC. Identification of Obesity and Cardiovascular Risk in Ethnically and Racially Diverse Populations. Circulation. 2015;132(5):457\u201372.","journal-title":"Circulation"},{"issue":"21","key":"2361_CR6","doi-asserted-by":"publisher","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","volume":"143","author":"TM Powell-Wiley","year":"2021","unstructured":"Powell-Wiley TM, Poirier P, Burke LE, Despr\u00e9s J-P, Gordon-Larsen P, Lavie CJ, Lear SA, Ndumele CE, Neeland IJ, Sanders P, et al. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021;143(21):e984\u20131010.","journal-title":"Circulation"},{"key":"2361_CR7","doi-asserted-by":"crossref","unstructured":"Yi Y, Yang L. Association between body roundness index and risks of all-cause and cardiovascular mortality in adults with metabolic dysfunction-associated steatotic liver disease: NHANES 1999\u20132018. Front Nutr. 2025;12\u20132025.","DOI":"10.3389\/fnut.2025.1604398"},{"issue":"1","key":"2361_CR8","doi-asserted-by":"publisher","first-page":"2259132","DOI":"10.1080\/10641963.2023.2259132","volume":"45","author":"X Cai","year":"2023","unstructured":"Cai X, Song S, Hu J, Zhu Q, Yang W, Hong J, Luo Q, Yao X, Li N. Body roundness index improves the predictive value of cardiovascular disease risk in hypertensive patients with obstructive sleep apnea: a cohort study. Clin Exp Hypertens. 2023;45(1):2259132.","journal-title":"Clin Exp Hypertens"},{"key":"2361_CR9","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.3389\/fnut.2022.883904","volume":"9","author":"X Yin","year":"2022","unstructured":"Yin X, -Y Chen J, -J Huang X, -H Lai J, Huang C, Yao W, -X Li N, -C Huang W, -G Guo X. Association between vitamin D serum levels and insulin resistance assessed by HOMA-IR among non-diabetic adults in the United States: Results from NHANES 2007\u20132014. Front Nutr. 2022;9:2022.","journal-title":"Front Nutr"},{"issue":"1","key":"2361_CR10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12933-024-02263-6","volume":"23","author":"A Colantoni","year":"2024","unstructured":"Colantoni A, Bucci T, Cocomello N, Angelico F, Ettorre E, Pastori D, Lip GYH, Del Ben M, Baratta F. Lipid-based insulin-resistance markers predict cardiovascular events in metabolic dysfunction associated steatotic liver disease. Cardiovasc Diabetol. 2024;23(1):175.","journal-title":"Cardiovasc Diabetol"},{"issue":"S1","key":"2361_CR11","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1111\/apt.17930","volume":"59","author":"SK Bansal","year":"2024","unstructured":"Bansal SK, Bansal MB. Pathogenesis of MASLD and MASH \u2013 role of insulin resistance and lipotoxicity. Aliment Pharmacol Ther. 2024;59(S1):S10\u201322.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"2361_CR12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12933-025-02724-6","volume":"24","author":"B Wang","year":"2025","unstructured":"Wang B, Li L, Tang Y, Ran X. Joint association of triglyceride glucose index (TyG) and body roundness index (BRI) with stroke incidence: a national cohort study. Cardiovasc Diabetol. 2025;24(1):164.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2361_CR13","doi-asserted-by":"publisher","first-page":"37276","DOI":"10.1038\/s41598-025-21331-9","volume":"15","author":"Z Li","year":"2025","unstructured":"Li Z, Ban Y, Hu M, Deng L, Xie X. Joint association of triglyceride-glucose index and obesity indicators with stroke risk: a nationwide prospective cohort study. Sci Rep. 2025;15(1):37276.","journal-title":"Sci Rep"},{"issue":"2","key":"2361_CR14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.7570\/jomes23031","volume":"32","author":"J-H Haam","year":"2023","unstructured":"Haam J-H, Kim BT, Kim EM, Kwon H, Kang J-H, Park JH, Kim K-K, Rhee SY, Kim Y-H, Lee KY. Diagnosis of Obesity: 2022 Update of Clinical Practice Guidelines for Obesity by the Korean Society for the Study of Obesity. JOMES. 2023;32(2):121\u20139.","journal-title":"JOMES"},{"issue":"12","key":"2361_CR15","doi-asserted-by":"publisher","first-page":"e016557","DOI":"10.1136\/bmjgh-2024-016557","volume":"9","author":"T Beaney","year":"2024","unstructured":"Beaney T, Kerr GK, Kiru G, McArdle H, Schlaich M, Schutte AE, Stergiou GS, Wang J-g, Marin MJ, Henandez-Hernandez R, et al. May Measurement Month 2022: results from the global blood pressure screening campaign. BMJ Global Health. 2024;9(12):e016557.","journal-title":"BMJ Global Health"},{"issue":"Supplement1","key":"2361_CR16","first-page":"S27","volume":"49","author":"Diabetes* ADAPPCf","year":"2025","unstructured":"Diabetes* ADAPPCf. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes\u20142026. Diabetes Care. 2025;49(Supplement1):S27\u201349.","journal-title":"Diabetes Care"},{"issue":"3","key":"2361_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.12997\/jla.2023.12.3.237","volume":"12","author":"E-S Jin","year":"2023","unstructured":"Jin E-S, Shim J-S, Kim SE, Bae JH, Kang S, Won JC, Shin M-J, Jin HY, Moon J, Lee H, et al. Dyslipidemia Fact Sheet in South Korea, 2022. J Lipid Atheroscler. 2023;12(3):237\u201351.","journal-title":"J Lipid Atheroscler"},{"issue":"2","key":"2361_CR18","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1093\/ije\/dyv316","volume":"46","author":"Y Kim","year":"2017","unstructured":"Kim Y, Han B-G. group tK: Cohort Profile: The Korean Genome and Epidemiology Study (KoGES) Consortium. Int J Epidemiol. 2017;46(2):e20\u201320.","journal-title":"Int J Epidemiol"},{"issue":"8","key":"2361_CR19","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.2337\/diacare.26.8.2426","volume":"26","author":"H Yokoyama","year":"2003","unstructured":"Yokoyama H, Emoto M, Fujiwara S, Motoyama K, Morioka T, Komatsu M, Tahara H, Shoji T, Okuno Y, Nishizawa Y. Quantitative Insulin Sensitivity Check Index and the Reciprocal Index of Homeostasis Model Assessment in Normal Range Weight and Moderately Obese Type 2 Diabetic Patients. Diabetes Care. 2003;26(8):2426\u201332.","journal-title":"Diabetes Care"},{"issue":"19","key":"2361_CR20","doi-asserted-by":"publisher","first-page":"e034768","DOI":"10.1161\/JAHA.124.034768","volume":"13","author":"M Yang","year":"2024","unstructured":"Yang M, Liu J, Shen Q, Chen H, Liu Y, Wang N, Yang Z, Zhu X, Zhang S, Li X, et al. Body Roundness Index Trajectories and the Incidence of Cardiovascular Disease: Evidence From the China Health and Retirement Longitudinal Study. J Am Heart Association. 2024;13(19):e034768.","journal-title":"J Am Heart Association"},{"issue":"19","key":"2361_CR21","doi-asserted-by":"publisher","first-page":"3344","DOI":"10.3390\/nu16193344","volume":"16","author":"I-H Lin","year":"2024","unstructured":"Lin I-H, Yu Y-P, Duong TV, Nien S-W, Tseng I-H, Wu Y-M, Chiang Y-J, Chiang C-Y, Chiu C-H, Wang M-H, et al. Effect of Obesity and Metabolic Health Status on Metabolic-Associated Steatotic Liver Disease among Renal Transplant Recipients Using Hepatic Steatosis Index. Nutrients. 2024;16(19):3344.","journal-title":"Nutrients"},{"issue":"3","key":"2361_CR22","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","volume":"81","author":"F Tacke","year":"2024","unstructured":"European Association for the Study of the L, European Association for the Study of D, European Association for the Study of O, Tacke F, Horn P, Wai-Sun Wong V, Ratziu V, Bugianesi E, Francque S, Zelber-Sagi S, et al. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024;81(3):492\u2013542.","journal-title":"J Hepatol"},{"issue":"2","key":"2361_CR23","doi-asserted-by":"publisher","first-page":"c154","DOI":"10.1159\/000327596","volume":"119","author":"R de Mutsert","year":"2011","unstructured":"de Mutsert R, de Jager DJ, Jager KJ, Zoccali C, Dekker FW. Interaction on an additive scale. Nephron Clin Pract. 2011;119(2):c154\u2013157.","journal-title":"Nephron Clin Pract"},{"issue":"20","key":"2361_CR24","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, Coresh J, Baker-Smith CM, Carnethon MR, Despr\u00e9s J-P, et al. A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association. Circulation. 2023;148(20):1636\u201364.","journal-title":"Circulation"},{"key":"2361_CR25","doi-asserted-by":"crossref","unstructured":"Zhou X-D, Fan Q-Y, Targher G, Byrne CD, Chen Q-F, Shapiro MD, Dong Y, Sung K-C, Lip GYH, Lazarus JV, et al. MASLD as a systemic metabolic disease: expanding the scope of cardiovascular-kidney-metabolic (CKM) syndrome. Sci China Life Sci. 2026.","DOI":"10.1007\/s11427-025-3193-9"},{"issue":"2","key":"2361_CR26","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1002\/ehf2.13820","volume":"9","author":"J Wang","year":"2022","unstructured":"Wang J, Wu M, Wu S, Tian Y. Relationship Between Body Roundness Index and the Risk of Heart Failure in Chinese Adults: The Kailuan Cohort Study. ESC Heart Fail. 2022;9(2):1328\u201337.","journal-title":"ESC Heart Fail"},{"issue":"12","key":"2361_CR27","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.metabol.2005.06.014","volume":"54","author":"S Ryu","year":"2005","unstructured":"Ryu S, Sung KC, Chang Y, Lee W-Y, Rhee E-J. Spectrum of insulin sensitivity in the Korean population. Metabolism - Clin Experimental. 2005;54(12):1644\u201351.","journal-title":"Metabolism - Clin Experimental"},{"key":"2361_CR28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ejim.2017.03.006","volume":"41","author":"G Gutierrez-Buey","year":"2017","unstructured":"Gutierrez-Buey G, N\u00fa\u00f1ez-C\u00f3rdoba JM, Llavero-Valero M, Gargallo J, Salvador J, Escalada J. Is HOMA-IR a potential screening test for non-alcoholic fatty liver disease in adults with type 2 diabetes? Eur J Intern Med. 2017;41:74\u20138.","journal-title":"Eur J Intern Med"},{"issue":"9","key":"2361_CR29","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3390\/nu16091381","volume":"16","author":"B Zy\u015bk","year":"2024","unstructured":"Zy\u015bk B, Ostrowska L, Smarkusz-Zarzecka J, Orywal K, Mroczko B, Cwalina U. Evaluation of the Diagnostic Utility of Selected Serum Adipokines and Cytokines in Subjects with MASLD\u2014A Pilot Study. Nutrients. 2024;16(9):1381.","journal-title":"Nutrients"},{"issue":"10","key":"2361_CR30","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1007\/s00125-017-4340-1","volume":"60","author":"E Isokuortti","year":"2017","unstructured":"Isokuortti E, Zhou Y, Peltonen M, Bugianesi E, Clement K, Bonnefont-Rousselot D, Lacorte J-M, Gastaldelli A, Schuppan D, Schattenberg JM, et al. Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory study. Diabetologia. 2017;60(10):1873\u201382.","journal-title":"Diabetologia"},{"key":"2361_CR31","doi-asserted-by":"crossref","unstructured":"Radmehr M, Homayounfar R, Djazayery A. The relationship between anthropometric indices and non-alcoholic fatty liver disease in adults: a cross-sectional study. Front Nutr. 2025;11\u20132024.","DOI":"10.3389\/fnut.2024.1494497"},{"issue":"1","key":"2361_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12944-025-02544-3","volume":"24","author":"S Khanmohammadi","year":"2025","unstructured":"Khanmohammadi S, Fallahtafti P, Habibzadeh A, Ezzatollahi Tanha A, Alamdari AA, Fallahtafti P, Shafi Kuchay M. Effectiveness of body roundness index for the prediction of nonalcoholic fatty liver disease: a systematic review and meta-analysis. Lipids Health Dis. 2025;24(1):117.","journal-title":"Lipids Health Dis"},{"issue":"7","key":"2361_CR33","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2337\/dci24-0094","volume":"48","author":"K Cusi","year":"2025","unstructured":"Cusi K, Abdelmalek MF, Apovian CM, Balapattabi K, Bannuru RR, Barb D, Bardsley JK, Beverly EA, Corbin KD, ElSayed NA, et al. Metabolic Dysfunction\u2013Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association. Diabetes Care. 2025;48(7):1057\u201382.","journal-title":"Diabetes Care"},{"issue":"2","key":"2361_CR34","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jhep.2025.02.033","volume":"83","author":"GR Steinberg","year":"2025","unstructured":"Steinberg GR, Valvano CM, De Nardo W, Watt MJ. Integrative metabolism in MASLD and MASH: Pathophysiology and emerging mechanisms. J Hepatol. 2025;83(2):584\u201395.","journal-title":"J Hepatol"},{"issue":"10","key":"2361_CR35","doi-asserted-by":"publisher","first-page":"5554","DOI":"10.1111\/dom.16601","volume":"27","author":"PC Eng","year":"2025","unstructured":"Eng PC, Teo AED, Leow MKS, Tai ES, Khoo CM. Body roundness index (BRI) and obesity-related anthropometrics: Relationship to visceral adiposity, insulin sensitivity index and cardiometabolic risk. Diabetes Obes Metabolism. 2025;27(10):5554\u201365.","journal-title":"Diabetes Obes Metabolism"},{"issue":"4","key":"2361_CR36","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3350\/cmh.2023.0035","volume":"29","author":"H-K Kim","year":"2023","unstructured":"Kim H-K, Bae S-J, Lee MJ, Kim EH, Park H, Kim HS, Cho YK, Jung CH, Lee WJ, Choe J. Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity. CMH. 2023;29(4):987\u20131001.","journal-title":"CMH"},{"issue":"Suppl","key":"2361_CR37","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.3350\/cmh.2022.0398","volume":"29","author":"E Ko","year":"2023","unstructured":"Ko E, Yoon EL, Jun DW. Risk factors in nonalcoholic fatty liver disease. CMH. 2023;29(Suppl):S79\u201385.","journal-title":"CMH"},{"issue":"4","key":"2361_CR38","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3803\/EnM.2025.2590","volume":"40","author":"S Hong","year":"2025","unstructured":"Hong S, Park CY. From Old to New: A Comprehensive Review of Obesity Diagnostic Criteria and Their Implications. Endocrinol Metab (Seoul). 2025;40(4):517\u201322.","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"1","key":"2361_CR39","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1152\/physrev.00033.2011","volume":"93","author":"A Tchernof","year":"2013","unstructured":"Tchernof A, Despr\u00e9s JP. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013;93(1):359\u2013404.","journal-title":"Physiol Rev"},{"key":"2361_CR40","doi-asserted-by":"crossref","unstructured":"Shen D, Cai X, Hu J, Song S, Zhu Q, Ma H, Zhang Y, Ma R, Zhou P, Yang W, et al. Associating plasma aldosterone concentration with the prevalence of MAFLD in hypertensive patients: insights from a large-scale cross-sectional study. Front Endocrinol. 2024;15\u20132024.","DOI":"10.3389\/fendo.2024.1451383"},{"issue":"11","key":"2361_CR41","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1111\/liv.15377","volume":"42","author":"C Saponaro","year":"2022","unstructured":"Saponaro C, Sabatini S, Gaggini M, Carli F, Rosso C, Positano V, Armandi A, Caviglia GP, Faletti R, Bugianesi E, et al. Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals. Liver Int. 2022;42(11):2418\u201327.","journal-title":"Liver Int"},{"issue":"5","key":"2361_CR42","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.3748\/wjg.v21.i5.1650","volume":"21","author":"Q Pang","year":"2015","unstructured":"Pang Q, Zhang JY, Song SD, Qu K, Xu XS, Liu SS, Liu C. Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index. World J Gastroenterol. 2015;21(5):1650\u201362.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"2361_CR43","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1002\/hep.29639","volume":"67","author":"C Caussy","year":"2018","unstructured":"Caussy C, Alquiraish MH, Nguyen P, Hernandez C, Cepin S, Fortney LE, Ajmera V, Bettencourt R, Collier S, Hooker J, et al. Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis. Hepatology. 2018;67(4):1348\u201359.","journal-title":"Hepatology"},{"issue":"0","key":"2361_CR44","first-page":"155982762413133","volume":"0","author":"A Farinetti","year":"2025","unstructured":"Farinetti A, Cocchi C, Coppi F, Mattioli AV. The Exposome, Social Determinants, and Environmental Pollution: Comprehensive Cardiovascular Risk in Women. Am J Lifestyle Med. 2025;0(0):15598276241313329.","journal-title":"Am J Lifestyle Med"},{"issue":"2","key":"2361_CR45","first-page":"e250036","volume":"7","author":"G Micheloni","year":"2025","unstructured":"Micheloni G, Cocchi C, Sinigaglia G, Coppi F, Zanini G, Moscucci F, Sciomer S, Nasi M, Desideri G, Gallina S, et al. Sustainability of the Mediterranean Diet: A Nutritional and Environmental Imperative. J Sustain Res. 2025;7(2):e250036.","journal-title":"J Sustain Res"},{"issue":"20","key":"2361_CR46","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.2174\/0113816128302667240422110226","volume":"30","author":"L Jing","year":"2024","unstructured":"Jing L, Yiwen H, Chunxia H, Fengjie J, Xihong Z, Yulong Y. The Regulation of Selenoproteins in Diabetes: A New Way to Treat Diabetes. Curr Pharm Design. 2024;30(20):1541\u20137.","journal-title":"Curr Pharm Design"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02361-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02361-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02361-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:04:41Z","timestamp":1789988681000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02361-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2361"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02361-4","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"5 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The KoGES Ansan-Ansung cohort protocol was approved by the Institutional Review Board (IRB) of the KDCA. All participants provided written informed consent. The study protocol adhered to the ethical principles outlined in the 1964 Declaration of Helsinki and its subsequent revisions. This study was approved by the of Gangnam Severance Hospital (IRB No. 3-2023-0277).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"276"}}